Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer

Huang, M.-R.M.-R.HuangHsu, Y.-L.Y.-L.HsuTAI-CHIA LINCheng, T.-J.T.-J.ChengLi, L.-W.L.-W.LiTseng, Y.-W.Y.-W.TsengChou, Y.-S.Y.-S.ChouLiu, J.-H.J.-H.LiuSZU-HUA PANFang, J.-M.J.-M.FangWong, C.-H.C.-H.Wong2021-06-042021-06-0420190223-5234https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069924450&doi=10.1016%2fj.ejmech.2019.07.054&partnerID=40&md5=81a3b3af9865fefc5e09c8c515bc4234https://scholars.lib.ntu.edu.tw/handle/123456789/565087[SDGs]SDG3Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancerjournal article10.1016/j.ejmech.2019.07.054313765672-s2.0-85069924450